Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Sells Shares to Cover Tax Obligations

Paula Green, SVP of Human Resources at Twist Bioscience, sold 1,101 shares of common stock on May 5, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 5, 2025, Paula Green, the SVP of Human Resources at Twist Bioscience Corp, sold 1,101 shares of the company's common stock.
• The sale was executed at a price of $37.651 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Paula Green directly owns 129,380 shares of Twist Bioscience Corp.
• The sale was mandated by Twist Bioscience's equity incentive plan, which requires a 'sell to cover' transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations and does not indicate a change in the executive's confidence in the company.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest. The sale itself is unlikely to have a significant impact on the company's stock price, as it is a relatively small transaction and is driven by tax considerations rather than a change in the executive's outlook on the company.

Comparison to Industry Standards

• Sell-to-cover transactions are a standard practice across publicly traded companies, particularly in the technology and biotechnology sectors where stock-based compensation is prevalent.
• Companies like Illumina, Agilent, and Thermo Fisher Scientific also utilize equity incentive plans that often result in similar sell-to-cover transactions by their executives.
• The number of shares sold and the value of the transaction are relatively small compared to the overall market capitalization of Twist Bioscience, aligning with typical sell-to-cover activities observed in comparable companies.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, as it is a small sale related to tax obligations.
• Employees may be interested in the details of the company's equity incentive plan and how it affects their own stock-based compensation.

Key Dates

Keywords

Twist Bioscience, Paula Green, stock sale, Form 4, insider trading, tax withholding, restricted stock units, equity incentive plan